Differential expression of cutaneous lymphocyte antigen in lymphomatoid papulosis and lymphomas is a potential marker for diagnosis and tumor progression

被引：0
|
作者：
Kadin, ME
Nacem, H
Kieffer, D
King, S
Severy, P
Pinkus, JL
Pinkus, GS
Kupper, TS
机构：
[1] Harvard Univ, Sch Med, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2004年 / 122卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
178
引用
收藏
页码：A30 / A30
页数：1
相关论文
共 46 条
  • [21] Tumor infiltrating B cells in primary cutaneous T-cell lymphomas correlate with disease progression and might represent a potential target for therapy
    Von Bergwelt, M.
    Schlaak, M.
    Kurschat, P.
    Stadler, R.
    Theurich, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S159 - S160
  • [22] Differential expression of CCR4 in primary cutaneous gamma/delta (γ/δ) T cell lymphomas and mycosis fungoides: Significance for diagnosis and therapy
    Jour, George
    Aung, Phyu P.
    Merrill, E. Dean
    Curry, Jonathan L.
    Tetzlaff, Michael T.
    Nagarajan, Priyadharsini
    Ivan, Doina
    Prieto, Victor G.
    Duvic, Madeleine
    Miranda, Roberto N.
    Torres-Cabala, Carlos A.
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2018, 89 (01) : 88 - 91
  • [23] Tumor-infiltrating B-Cells in primary cutaneous T-Cell Lymphoma Progression Marker and potential Therapeutic Target
    Schlaak, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (11): : 1128 - 1128
  • [24] Differential expression of microRNA miR-150-5p in IgA nephropathy as a potential mediator and marker of disease progression
    Pawluczyk, Izabella Z. A.
    Didangelos, Athanasios
    Barbour, Sean J.
    Er, Lee
    Becker, Jan U.
    Martin, Roberto
    Taylor, Scott
    Bhachu, Jasraj S.
    Lyons, Edward G.
    Jenkins, Robert H.
    Fraser, Donald
    Molyneux, Karen
    Perales-Paton, Javier
    Saez-Rodriguez, Julio
    Barratt, Jonathan
    KIDNEY INTERNATIONAL, 2021, 99 (05) : 1127 - 1139
  • [25] Expression of the PRAME immunohistochemical marker in melanocytic lesions: a potential biomarker and its role in differential diagnosis of malignant lesions
    Mod, B. Noyan
    Leblebici, C.
    VIRCHOWS ARCHIV, 2024, 485 : S36 - S37
  • [26] Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma
    Clarijs, R
    Schalkwijk, L
    Hofmann, UB
    Ruiter, DJ
    de Waal, RMW
    CANCER RESEARCH, 2002, 62 (23) : 7059 - 7065
  • [27] EXPRESSION OF CARCINOEMBRYONIC ANTIGEN BY ADENOMA AND CARCINOMA DERIVED EPITHELIAL-CELL LINES - POSSIBLE MARKER OF TUMOR PROGRESSION AND MODULATION OF EXPRESSION BY SODIUM-BUTYRATE
    BERRY, RD
    PARASKEVA, C
    CARCINOGENESIS, 1988, 9 (03) : 447 - 450
  • [28] Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis
    Churchill, Hywyn R. O.
    Roncador, Giovanna
    Warnke, Roger A.
    Natkunam, Yasodha
    HUMAN PATHOLOGY, 2010, 41 (12) : 1726 - 1734
  • [29] THE USE OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) EXPRESSION AND INTRAEPITHELIAL LYMPHOCYTE COUNT IN THE DIFFERENTIAL-DIAGNOSIS OF INFLAMMATORY BOWEL-DISEASE
    KELLER, K
    KOCH, HK
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1994, 26 (05): : 233 - 237
  • [30] Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: A new molecular marker potentially involved in tumor progression
    Comincini, S
    Facoetti, A
    Del Vecchio, I
    Peoc'h, K
    Laplanche, JL
    Magrassi, L
    Ceroni, M
    Ferretti, L
    Nano, R
    ANTICANCER RESEARCH, 2004, 24 (3A) : 1507 - 1517
12345